欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7288/001
药品名称Clindamycin Noridem 150 mg/ml Injektions-/Infusionslösung
活性成分
    • Clindamycin phosphate 150.0 mg/ml
剂型Solution for injection/infusion
上市许可持有人Noridem Enterprises Limited Evagorou and Makariou Mitsi Building 3 Office 115 CY-1065 Nicosia Cyprus
参考成员国 - 产品名称Germany (DE)
Clindamycin Noridem 150 mg/ml Injektions-/Infusionslösung
互认成员国 - 产品名称
    • Italy (IT)
    • Ireland (IE)
    • Cyprus (CY)
      Clindamycin Noridem 150 mg/ml διάλυμα για ένεση/έγχυση
    • Greece (EL)
    • Sweden (SE)
    • Norway (NO)
    • Denmark (DK)
      Clindamycin Noridem
    • Finland (FI)
    • Belgium (BE)
    • Poland (PL)
    • Netherlands (NL)
    • Hungary (HU)
    • Austria (AT)
    • Czech Republic (CZ)
      Clindamycin noridem
    • France (FR)
    • Romania (RO)
      Clindamycin Noridem 150 mg/ml
    • Spain (ES)
    • Slovak Republic (SK)
    • Portugal (PT)
许可日期2023/04/13
最近更新日期2025/11/11
药物ATC编码
    • J01FF01 clindamycin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase